Latest Regulatory News

Epsilon Healthcare Limited has unveiled a comprehensive pre-reinstatement disclosure, highlighting improved financial health and a strategic growth plan focused on operational stability and expansion.

Jumbo Interactive will subcontract with Brightstar Lottery PLC to deliver key components of Lotterywest’s new gaming and digital platform, marking a significant collaboration in the lottery technology space.

Legacy Iron Ore has ceased mining operations at Mt Celia, marking the end of Phase I, while advancing heap leach studies and exploring a Carbon-in-Leach plant to drive future growth.

Arena REIT reports a $61 million uplift in portfolio valuation for H1 FY2026, driven by strong investor interest in early learning centres and a tightening yield environment. The company reaffirms its FY2026 distribution guidance, signaling confidence in its growth trajectory.

TasFoods Ltd has secured shareholder approval to sell its Pyengana Dairy business and to execute a selective buy-back of nearly 50 million shares, marking a pivotal moment in its strategic reshaping.

Native Mineral Resources has secured the Estimated Rehabilitation Cost decision, unlocking mining activities at the Podosky site with drilling set for January 2026 and ore processing targeted by late February.

Verbrec Limited has announced over $20 million in new contracts spanning biogas engineering, cyber security, pipeline maintenance, mining technology, and water security, reinforcing its leadership in energy transition and sustainable mining sectors.

Avecho Biotechnology is close to completing recruitment for the interim analysis cohort of its pivotal Phase III trial testing a CBD capsule for insomnia, with results expected in the first half of 2026.

Micro-X Limited has secured $6 million through a share placement to accelerate commercialisation of its innovative medical imaging technologies, with strategic partner Billion Prima increasing its stake to 8.5%. The capital raise supports key clinical trials and product development milestones.

Micro-X has raised $6.18 million through a placement that sees strategic partner Billion Prima increase its stake to 8.6%, funding key commercial and manufacturing scale-up initiatives in medical imaging.

Cleo Diagnostics has raised $5 million to support the U.S. commercial launch of its Pre-Surgical Ovarian Cancer Test and accelerate development of a mass screening test, signaling strong investor confidence in its technology.

Mount Ridley Mines has locked in nearly $1.8 million through a fully underwritten exercise of expiring unlisted options, ensuring financial backing for its Mount Ridley Project exploration and metallurgical programs.